entertainment -WSS

entertainment

author：leisure time 2025-10-01 21:10:08 - browse：5619

Neurocrine Biosciences decided to join PhRMA. Adobe

WASHINGTON — Neurocrine Biosciences, a biotech company based in California, has joined the drug lobbying organization PhRMA, the group announced on Thursday.

The addition is a step toward rebuilding PhRMA’s ranks after high-profile departures that followed the passage of Democrats’ drug pricing law, though both Neurocrine and the other company that joined since are smaller than those that exited.

The company is a relatively big spender on lobbying, especially for its size. Neurocrine spent $3.1 million on its federal advocacy efforts last year alone. Compare that with Vertex Pharmaceuticals, which spent virtually the same amount on lobbying, even as it brought in nearly quadruple the net income that Neurocrine Biosciences did last year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Stephen Quake on the Chan Zuckerberg quest to conquer disease

WSS

Russia strikes Ukraine's critical port facilities in Odesa after halting grain deal

Gilgo Beach murders: What questions remain following Rex Heuermann's arrest?

New report analyzes digital physical therapy solutions' effectiveness

STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

Coercive sterilizations revealed by STAT prompt outrage

Celebrate National Dole Whip Day for 3 days this week at Disney

Wikipedia

entertainment

explore

DIEP, the 'gold standard' of breast reconstruction, is under threat

Health care court cases: Humana, Sutter, Novant

Anesthesiologist group: stop taking Ozempic before surgery

How dance can help health care workers heal from trauma

Malaria cases in Florida and Texas: Here’s what you need to know

Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

Sports medicine is finally prioritizing gender equality

ALS patient reclaims some autonomy thanks to wearable 'robot'

BioMarin wins approval for gene therapy to treat hemophilia A

Coercive sterilizations revealed by STAT prompt outrage

hotspot

TikTok cracks down on users posting about weight loss drugs

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

Plane’s emergency slide plummets from sky, hits Chicago home

My daughter's legacy lives on through her writing, phage therapy

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

Health care court cases: Humana, Sutter, Novant

focus

focus

focus

leisure time